info@seagull-health.com
SeagullHealth
语言:
search
new
What Are the Common Side Effects of Adagrasib?
506
Article source: Seagull Pharmacy
Apr 29, 2026

Adagrasib is a targeted therapy for KRAS G12C mutations, used as monotherapy for non-small cell lung cancer and in combination with cetuximab for colorectal cancer.

What Are the Common Side Effects?

1. Monotherapy for Non-Small Cell Lung Cancer:

(1) Nausea, diarrhea, vomiting, fatigue, musculoskeletal pain, liver injury, kidney injury, edema, decreased appetite, shortness of breath.

(2) Common laboratory abnormalities include lymphopenia, decreased hemoglobin, elevated AST, hyponatremia, increased creatinine.

2. Combination with Cetuximab for Colorectal Cancer:

Rash, nausea, diarrhea, vomiting, fatigue, musculoskeletal pain, liver injury, headache, dry skin, abdominal pain, decreased appetite, edema, anemia, cough.

II. Serious Side Effects and Management

The following serious side effects require high vigilance; seek medical attention immediately if signs appear:

1. Severe Gastrointestinal Reactions:

(1) May include gastrointestinal bleeding, intestinal obstruction, colitis.

(2) If persistent severe nausea, vomiting, diarrhea, blood in stool, or severe abdominal pain occur, prompt management is needed.

(3) Doctors may administer antiemetics, antidiarrheals, and supportive hydration.

2. QT Prolongation:

(1) 6% of monotherapy patients had QTc ≥501 ms, and 11% had an increase from baseline >60 ms.

(2) May increase the risk of torsade de pointes and sudden death.

(3) Monitor ECG and potassium/magnesium levels before and during treatment.

(4) If QTc >500 ms or increased from baseline >60 ms, withhold the drug.

(5) Contraindicated in patients with congenital long QT syndrome or pre-existing QTc prolongation.

3. Liver Injury:

(1) Elevated transaminases occur in some patients; 7% had grade 3-4 elevations; 0.3% developed drug-induced liver injury.

(2) Check liver function monthly before treatment and for the first 3 months of treatment.

(3) Seek immediate medical attention if jaundice, dark urine, fatigue, decreased appetite, right upper quadrant pain, or bleeding tendency occur.

4. Interstitial Lung Disease/Pneumonitis:

(1) Can be fatal.

(2) Seek immediate medical attention if new or worsening shortness of breath, cough, or fever occur.

(3) Permanently discontinue the drug once diagnosed.

Lifestyle and Care Measures to Alleviate Side Effects

1. Nausea and Vomiting:

(1) Choose bland, easy-to-digest foods and eat small, frequent meals.

(2) Avoid greasy, spicy, or overly sweet foods.

Antiemetics (e.g., ondansetron) may be used under medical guidance.

2. Diarrhea:

(1) Replenish fluids and electrolytes (e.g., oral rehydration solution) to prevent dehydration.

(2) Avoid high-fiber, dairy, and greasy foods.

(3) Doctors may prescribe antidiarrheals such as loperamide.

(4) Withhold the drug for severe diarrhea.

3. Fatigue:

(1) Balance rest with mild activity (e.g., short walks).

(2) Ensure adequate sleep. If fatigue significantly affects daily life, inform your doctor for possible dose reduction.

4. Rash/Dry Skin:

(1) Use gentle, fragrance-free moisturizer daily.

(2) Avoid direct sunlight; wear sunscreen and long sleeves when outdoors.

(3) Do not scratch or squeeze rashes. Severe rash requires dermatology evaluation.

5. Musculoskeletal Pain:

(1) Apply local heat or gentle massage.

(2) Use acetaminophen if necessary for pain relief (confirm it does not interact with other medications).

6. Decreased Appetite:

(1) Eat small, frequent meals and choose nutrient-dense foods.

(2) Consider nutritional supplements (e.g., Ensure, TPN).

(3) Inform your doctor if significant weight loss occurs.

7. Edema:

(1) Elevate legs appropriately and reduce salt intake.

(2) Monitor body weight and leg circumference regularly.

Drug Storage Conditions

1. Temperature:

Room temperature 20°C to 25°C (68°F to 77°F); brief excursions permitted between 15°C and 30°C (59°F to 86°F) (e.g., when traveling).

2. Protection from Moisture:

(1) Store in the original bottle, which contains a desiccant pouch – do not remove.

(2) Tightly close the cap after each use.

3. Original Container:

Keep in the original child-resistant high-density polyethylene (HDPE) bottle with a tight seal.

4. Storage Location:

Keep out of reach of children to prevent accidental ingestion.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Adagrasib(Krazati)
Adagrasib(Krazati)
Locally advanced or metastatic NSCLC harboring KRAS G12C mutation who have...
WeChat Scan
Free Inquiry
Recommended Articles
Is Adagrasib available in China?
Adagrasib is a novel targeted therapy for the KRAS G12C mutation and has not yet been officially approved for sale in mainland China. Patients needing this drug must obtain it through specific legal c...
Indications of Azacitidine Tablets
Azacitidine tablets are an oral maintenance therapy. Correctly understanding the indicated population, contraindications, and special population medication rules is a prerequisite for ensuring efficac...
Dosage and Administration of Azacitidine Tablets
Azacitidine tablets are a key maintenance therapy drug for acute myeloid leukemia, and standardized medication and health management are equally important.Dosage and Administration of Azacitidine Tabl...
Dosage and Administration of Valcyte
Valcyte (valganciclovir) is a prescription antiviral medication. Proper dosage, strict precautions, and a healthy lifestyle are effective measures to ensure efficacy and safety.Dosage and Administrati...
Indications for Niraparib
Niraparib (Zejula) is a PARP inhibitor indicated for maintenance treatment of certain patients with ovarian cancer.Indications for Niraparib1. First-line Maintenance Treatment of Advanced Ovarian Canc...
Common Side Effects Niraparib
Niraparib (Zejula), as a PARP inhibitor, can prolong survival in patients with ovarian cancer but may also cause a range of adverse reactions.Common Side Effects1. Hematologic ReactionsThrombocytopeni...
Common side effects of fidaxomicin (Dificid)
Fidaxomicin (Dificid) is a specialized antibiotic for the treatment of Clostridioides difficile-associated diarrhea, with a good safety profile.Common side effects of fidaxomicin (Dificid)1. Common si...
Indications: Only for Clostridioides difficile-associated diarrhea
Fidaxomicin (Dificid) is a macrolide antibiotic specifically indicated for Clostridioides difficile-associated diarrhea, acting locally in the intestine with minimal systemic absorption.Indications: O...
Related Articles
What Are the Common Side Effects of Adagrasib?
Adagrasib is a targeted therapy for KRAS G12C mutations, used as monotherapy for non-small cell lung cancer and in combination with cetuximab for colorectal cancer.What Are the Common Side Effects?1. ...
Is Adagrasib available in China?
Adagrasib is a novel targeted therapy for the KRAS G12C mutation and has not yet been officially approved for sale in mainland China. Patients needing this drug must obtain it through specific legal c...
Precautions for Adagrasib Administration
Adagrasib is an irreversible inhibitor of KRASG12C, primarily indicated for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) with KRASG12C...
Side Effects of Adagrasib
Adagrasib is an irreversible inhibitor of KRASG12C mutation, indicated for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) with KRASG12C ...
Dosage and Administration of Adagrasib
Adagrasib is an irreversible inhibitor of KRASG12C mutation, mainly used for the treatment of non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) with specific gene mutations.Dosage and Adm...
What Are the Indications of Adagrasib?
Adagrasib is an innovative KRASG12C inhibitor, which was first approved for marketing in the United States in 2022. As a major breakthrough in the field of targeted therapy, this medication provides a...
What Are the Purchase Channels for Adagrasib?
Adagrasib is an innovative KRASG12C-targeted inhibitor that has shown promising efficacy in the treatment of non-small cell lung cancer and colorectal cancer.What Are the Purchase Channels for Adagras...
Precautions for use of Adagrasib
Adagrasib is an important therapeutic drug, and its correct use and precautions are crucial to ensure the therapeutic effect.Precautions for use of AdagrasibUnderstanding and following the precau...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved